Cited by 7Prostate Cancer Treatment and ResearchNanoparticle-Based Drug DeliveryHormonal and reproductive studies

Testosterone-loaded GM1 micelles targeted to the intracellular androgen receptor for the specific induction of genomic androgen signaling

Open access
Peinetti, Nahuel, Cuello Rubio, Mariana Micaela, Sosa, Liliana Del Valle, Scalerandi, María Victoria, Alasino, Roxana Valeria, Peyret, Victoria, Nicola, Juan Pablo, Beltramo, Dante Miguel +2 more·2020·International Journal of Pharmaceutics

Abstract

Androgens play a central role in homeostatic and pathological processes of the prostate gland. At the cellular level, testosterone activates both the genomic signaling pathway, through the intracellular androgen receptor (AR), and membrane-initiated androgen signaling (MIAS), by plasma membrane receptors. We have previously shown that the activation of MIAS induces uncontrolled proliferation and fails to stimulate the beneficial immunomodulatory effects of testosterone in prostatic cells, becoming necessary to investigate if genomic signaling mediates homeostatic effects of testosterone. However, the lack of specific modulators for genomic androgen signaling has delayed the understanding of this mechanism. In this article, we demonstrate that monosialoganglioside (GM1) micelles are capable of delivering testosterone into the cytoplasm to specifically activate genomic signaling. Stimulation with testosterone-loaded GM1 micelles led to the activation of androgen response element (ARE)-regulated genes in vitro as well as to the recovery of normal prostate size and histology after castration in mice. In addition, these micelles avoided MIAS, as demonstrated by the absence of rapid signaling pathway activation and the inability to induce uncontrolled cell proliferation. In conclusion, our results validate a novel tool for the specific activation of genomic androgen signaling and demonstrate the importance of selective pathway activation in androgen-mediated proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2020.119985

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Testosterone-loaded monosialoganglioside micelles bypass the effects of membrane-initiated signaling to target DNA-binding-dependent signaling exclusively by directly delivering testosterone to the cytoplasm.

    “One such example of this was the recently developed testosterone loaded monosialoganglioside micelles, which were able to bypass the effects of membrane‐initiated signaling to target DNA binding‐dependent signaling exclusively by the micelle directly delivering testosterone to the cytoplasm.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 63 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Peinetti, N., Cuello Rubio, M. M., Sosa, L. D. V., Scalerandi, M. V., Alasino, R. V., Peyret, V., Nicola, J. P., Beltramo, D. M., Quintar, A. A., & Maldonado, C. A.
Affiliations
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • Universidad Católica de Córdoba (AR)
Corresponding author
Quintar, Amado Alfredo
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2020-12
Volume
591
Pages
119985
ISSN
0378-5173 (ISSN-L)
OpenAlex
W3093134269
Cited by
7
References
63
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1
FWCI
0.42
Type
journal article
Language
en
Open access
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • Conicet (submittedVersion, cc-by-nc-sa)
Funders
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
testosterone, androgen response element, prostate, castration, drug delivery, cell proliferation, immunomodulation
MeSH terms
Androgens, Animals, G(M1) Ganglioside, Humans, Male, Micelles, Prostatic Neoplasms, Receptors, Androgen, Testosterone, Signal Transduction, Genomics, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review